Results 61 to 70 of about 4,613,372 (388)

Multi‐Functional Liposome: A Powerful Theranostic Nano‐Platform Enhancing Photodynamic Therapy

open access: yesAdvancement of science, 2021
Although photodynamic therapy (PDT) has promising advantages in almost non‐invasion, low drug resistance, and low dark toxicity, it still suffers from limitations in the lipophilic nature of most photosensitizers (PSs), short half‐life of PS in plasma ...
Xiamin Cheng   +12 more
semanticscholar   +1 more source

Photodynamic therapy in the treatment of onychomycosis – a review

open access: yesPrzegląd Dermatologiczny, 2017
Toenail onychomycosis is a common infection, affecting up to 14% of the population. Moreover, poor penetration of topical drugs into the nail bed leads to frequent recurrences of the disease. The cure rate of toenail onychomycosis is estimated at 63–76%.
Katarzyna Kalinowska   +1 more
doaj   +1 more source

Riboflavin and Its Derivates as Potential Photosensitizers in the Photodynamic Treatment of Skin Cancers

open access: yesCells, 2023
Riboflavin, a water-soluble vitamin B2, possesses unique biological and physicochemical properties. Its photosensitizing properties make it suitable for various biological applications, such as pathogen inactivation and photodynamic therapy. However, the
Małgorzata Insińska-Rak   +2 more
doaj   +1 more source

Cost effectiveness of treatments for wet age-related macular degeneration [PDF]

open access: yes, 2011
Age-related macular degeneration (AMD) is a leading cause of blindness in people aged >= 50 years. Wet AMD in particular has a major impact on patient quality of life and imposes substantial burdens on healthcare systems.
Annemans, Lieven   +4 more
core   +1 more source

Topical photodynamic therapy [PDF]

open access: yesArchive of Oncology, 2006
Topical photodynamic therapy is a therapeutic modality in development, thus arises grate interest among dermatologists worldwide. It is an effective therapy for actinic keratosis, superficial BCC and Bowenos disease.
Poljački Mirjana   +5 more
doaj   +1 more source

Gold Nanorod-Decorated Metallic MoS2 Nanosheets for Synergistic Photothermal and Photodynamic Antibacterial Therapy

open access: yesNanomaterials, 2021
Light-responsive nanocomposites have become increasingly attractive in the biomedical field for antibacterial applications. Visible-light-activated metallic molybdenum disulfide nanosheets (1T-MoS2 NSs) and plasmonic gold nanorods (AuNRs) with absorption
Sibidou Yougbaré   +7 more
doaj   +1 more source

Dual Role of Subphthalocyanine Dyes for Optical Imaging and Therapy of Cancer [PDF]

open access: yes, 2018
This is the peer-reviewed version of the following article: van de Winckel, E., Mascaraque, M., Zamarrón, A., Juarranz de la Fuente, Á., Torres, T., & de la Escosura, A. (2018).
Escosura Navazo, Andrés de la   +5 more
core   +1 more source

Photodynamic therapy: photosensitizers and nanostructures

open access: yesMaterials Chemistry Frontiers, 2021
Photodynamic therapy (PDT) uses photosensitizers (PSs) to treat some skin and eye diseases, and certain types of cancer. In this review, we summarise the strategies to design PSs and how they can be incorporated into different nanostructures.
A. Escudero   +5 more
semanticscholar   +1 more source

Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic Diagnosis

open access: yesAdvances in Pharmacological Sciences, 2010
Accumulating evidence indicates that ATP-binding cassette (ABC) transporter ABCG2 plays a key role in regulating the cellular accumulation of porphyrin derivatives in cancer cells and thereby affects the efficacy of photodynamic therapy and photodynamic ...
Toshihisa Ishikawa   +5 more
doaj   +1 more source

Verteporfin photodynamic therapy combined with intravitreal ranibizumab in neovascular age-related macular degeneration: 24-month follow-up

open access: yesSenses and Sciences, 2014
Purpose: to evaluate the efficacy and safety of combined therapy with Photodynamic Therapy with Verteporfin (PDT-V) and intravitreal ranibizumab same-day compared with monotherapy with ranibizumab (three monthly injections ) for the treatment of the ...
Rosalia Giustolisi   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy